Article
Prognostic Biomarker MUC4 Mutations in Colon Adenocarcinoma Correlating with Tumor Microenvironment
2021-01-07
Abstract excerpt
<h4>Background: </h4> Immunotherapy is a new strategy for Colorectal cancer (CRC) treatment. Tumor mutation burden (TMB) may act as an emerging biomarker for predicting responses to immunotherapy. Nevertheless, no studies investigate if these gene mutations correlate to TMB and tumor-infiltrating immune cells. <h4>Methods: </h4>: Somatic mutation data for CRC samples were obtained from The Cancer Genome Atlas (TCG...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4e06bfb3-9d2b-5bd8-81c9-d9adbaf98478
- DOI
- 10.21203/rs.3.rs-137615/v1
